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Abstract. The Zn2+-specific ion channel ZIP7 has been implicated to play an important role in releasing Zn2+ from the ER. 
External stimulation of breast cancer cells has been proposed to induce phosphorylation of ZIP7 by CK2α, resulting in ZIP7-
mediated Zn2+ release from the ER into the cytosol. Here, we examined whether changes in cytosolic and ER Zn2+ 
concentrations can be detected upon such external stimuli. Two previously developed FRET sensors for Zn2+, eZinCh-2 (Kd = 
1 nM at pH 7.1) and eCALWY-4 (Kd = 0.63 nM at pH 7.1), were expressed in both the cytosol and the ER of wild-type MCF-7 
and TamR cells. Treatment of MCF-7 and TamR cells  with external Zn2+ and pyrithione, one of the previously used triggers, 
resulted in an immediate increase in free Zn2+ in both cytosol and ER, suggesting that Zn2+ was directly transferred across 
the cellular membranes by pyrithione. Cells treated with a second trigger, EGF/ionomycin, showed no changes in 
intracellular Zn2+ levels, neither in multicolor imaging experiments that allowed simultaneous imaging of cytosolic and ER 
Zn2+, nor in experiments in which cytosolic and ER Zn2+ were monitored separately. In contrast to previous work using 
small-molecule fluorescent dyes, these results indicate that EGF-ionomycin treatment does not result in significant 
changes in cytosolic Zn2+ levels as a result from Zn2+ release from the ER. These results underline the importance of using 
genetically encoded fluorescent sensors to complement and verify intracellular imaging experiments with synthetic 
fluorescent Zn2+ dyes.  
Introduction 
Zn
2+
 is essential for proper cell function and cell growth
[1]
. 
However, excess Zn
2+
 can be toxic to cells, affecting growth 
and causing serious metabolic disorders
[2]
. How Zn
2+
 
participates in controlling cellular processes is an emerging 
area of interest. In addition to its well established roles as a 
Lewis acid cofactor in enzyme catalysis and its structural role in 
protein folding, several studies have recently proposed a role 
for Zn
2+
 as a secondary messenger in intracellular signal 
transduction pathways
[3-5]
. Fluorescent sensors that allow 
intracellular imaging of Zn
2+
 concentrations in living cells have 
proven crucial in our understanding of the molecular 
mechanisms of intracellular Zn
2+
 homeostasis and its putative 
signaling.  
 Whereas small molecule sensors continue to contribute 
valuable insights into the role of Zn
2+
 in numerous biological 
processes, their intracellular concentration and localization 
cannot be easily controlled. Therefore, we and others have 
developed fluorescent Zn
2+
 sensor proteins based on the 
modulation of  Fluorescence Energy Transfer (FRET) between a 
donor and acceptor fluorescent domain
[6-8]
. These genetically-
encoded sensors do not require cell-invasive procedures, their 
concentration and intracellular location can be tightly 
controlled, and the use of FRET allows for ratiometric 
detection. The eCALWY-sensors that were developed by our 
group consist of two small metal binding domains, ATOX1 and 
WD4, connected by a long flexible linker, with self-associating 
variants of cerulean and citrine fluorescent domains fused to 
the N- and C-terminus, respectively. A toolbox of 6 eCALWY 
variants has been developed that range in Zn
2+
 affinity 
between 2 pM and 5 nM. Of these, eCALWY-4 with a Kd of 630 
pM was found to be optimal for measuring cytosolic Zn
2+
 
concentrations, which typically reside in the 0.2-1 nM range, in 
a wide variety of cells
[6, 9]
. Replacement of Cerulean and Citrine 
by self-associating variants of mOrange and mCherry yielded 
the red-shifted redCALWY variants, whose spectral properties 
allowed them to be used in combination with CFP-YFP-based 
reporters
[10]
. Recently, we also reported another versatile FRET 
sensor containing a de novo Cys2His2 Zn
2+
 binding pocket 
created directly on the surface of Cerulean and Citrine 
domains
[11]
. This eZinCh-2 sensor displays a large increase in 
emission ratio upon binding Zn
2+
 at the interface of the two 
fluorescent domains, with an affinity that is similar to that of 
eCALWY-4. By default eCALWY-4 and eZinCh-2 reside in the 
cytosol, but both have been successfully targeted to the ER, 
mitochondria and secretory vesicles by the introduction of 
organelle specific targeting sequences
[11]
.  
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Because Zn
2+
 is unable to passively diffuse across cell 
membranes, active transport between the cytosol, the 
extracellular space and intracellular compartments is required 
to allow control over intracellular Zn
2+
 homeostasis. Two 
families of mammalian Zn
2+
 transporters are known that 
transport Zn
2+
 across cellular membranes. The ZnT (SLC30A) 
family exports Zn
2+
 from the cytosol into organelles or to the 
extracellular space
[12]
. The ZIP family (SLC39A) acts as an 
importer protein and is responsible for Zn
2+
 import from either 
the extracellular space or from different cellular 
compartments
[13]
. One of the ZIP family members, ZIP7, was 
found to localize on the membrane of the endoplasmic 
reticulum
[14, 15]
 and is believed to play a role in the 
transportation of Zn
2+
 from the ER into the cytosol. Zn
2+
 
transporters play a crucial role in maintaining the delicate 
balance between cell growth and cell death and aberrant 
functioning of Zn
2+
 transporters has been linked to several 
disease states including cancer. For example, Zn
2+
 was found 
to be increased in human breast tumors  
[16, 17]
. A widely used 
model to investigate the development of breast cancer
[18]
 
showed an up to 19-fold increase in total Zn
2+
 levels in 
mammary tumors in mice, rats and humans
[19]
. One 
mechanism by which increased levels of cytosolic Zn
2+
 could 
enhance cell proliferation is by the inhibition of protein 
tyrosine phosphatases, which could lead to a net increase in 
phosporylation of well-known cancer associated downstream 
effectors such as AKT and MAPK (mitogen-activated protein 
kinase)
[20, 21]
.  
Taylor and coworkers have proposed that phosphorylation 
of ZIP7 might induce release of Zn
2+
 from the ER to the cytosol 
in Tamoxifen-resistant MCF-7 breast cancer cells (TamR)
[22]
. 
Using the membrane-permeable Zn
2+
-specific indicator 
Newport Green DCF a 2-fold higher fluorescence was observed 
in TamR cells compared to wild-type MCF-7 cells, suggesting a 
higher intracellular free Zn
2+
 concentration 
[22]
. Comparison of 
the expression levels of several Zn
2+
 importers (ZIPs) revealed 
a significant increase in expression level of ZIP7 in TamR cells 
compared to wild-type MCF-7 cells. Since ZIP7 is almost 
exclusively localized on the ER membrane
[14]
, ZIP7 has been 
implicated to control the release of Zn
2+
 from the ER to the 
cytosol. Two types of triggers were used to study the 
involvement of ZIP7 in Zn
2+
 signaling in both wild-type MCF-7 
and TamR cells: the addition of extracellular Zn
2+
 with 
pyrithione, and addition of EGF with ionomycin. Addition of 
external Zn
2+
 and pyrithione to MCF-7 and TamR cells loaded 
with the Zn
2+
-specific fluorescent indicator FluoZin-3 showed 
an increase in green fluorescence within a few minutes after 
stimulation, which was interpreted to be a result of ZIP7-
dependent Zn
2+
 release from the ER
[21, 22]
. 
Immunoprecipitation experiments with a ZIP7 antibody in Zn
2+
 
treated cells showed co-immunoprecipitation of CK2α, 
suggesting that this kinase may be responsible for 
phosphorylation of ZIP7. Consistent with this role, a peak in 
the physical association between protein kinase CK2 and ZIP7 
was observed within two minutes after treatment with 
Zn
2+
/pyrithione. In addition, a proximity ligation assay, in 
which fluorescent dots appear when two molecules are in 
close proximity, showed significant association of ZIP7 and 
CK2α in the same timeframe.  
Based on the above results a model was proposed whereby 
the phosphorylation of ZIP7 by CK2 results in ZIP7-mediated 
Zn
2+
 release from ER stores into the cytosol, resulting in 
subsequent activation of several downstream signaling 
pathways
[22]
. However, the evidence for Zn
2+
 release from the 
ER upon external stimuli has remained indirect, because these 
studies did not directly measure ER Zn
2+
 levels. In addition, 
FluoZin-3 and the other synthetic fluorescent sensors that 
were employed to monitor intracellular Zn
2+
, are known to not 
only localize in the cytosol, but also to different cellular 
compartments, such as the Golgi, synaptic vesicles and the 
nucleus
[23]
. Here, we report the use of two previously 
developed FRET sensors for Zn
2+
 (eZinCh-2 (Kd = 1 nM) and 
eCALWY-4 (Kd = 0.63 nM)) to test the hypothesis that Zn
2+
 is 
released from the ER into the cytosol upon external stimuli 
(Table 1). Unlike synthetic fluorescent sensors, these 
genetically encoded sensors can be targeted exclusively to 
either the cytosol or the ER. Moreover, the use of two 
different color variants allowed us to simultaneously monitor 
the free Zn
2+
 concentration in the cytosol and ER within the 
same cell. Using these sensors an immediate increase in both 
cytosolic and ER Zn
2+
 levels was observed upon treatment of 
MCF7 and TAMR cells with Zn
2+
/pyrithione, which is consistent 
with direct, pyrithione-mediated exchange of Zn
2+
 between 
the cell exterior and intracellular compartments. In contrast, 
addition of EGF/ionomycin did not induce significant changes 
in cytosolic or ER Zn
2+
 concentrations. The implication of these 
findings for the putative role of ZIP7 in controlled release of 
Zn
2+
 from the ER will be discussed.     
a. cerulean: excitation maximum at 435 nm, emission maximum at 
475 nm; citrine: excitation maximum at 510 nm, emission 
maximum at 535 nm.  
b. mOrange2: excitation maximum at 549 nm, emission maximum 
at 565 nm;  mCherry: excitation maximum at 587 nm, emission 
maximum at 610 nm. 
c.  ER-targeted sensor variants contained an N-terminal insulin 
signal peptide,  and a C-termical KDEL retention sequence.  
 
 
Table 1: Overview of FRET sensors used in this study 
Sensor  Fluorescent 
domains  
(donor/acceptor)  
K
d
 for Zn
2+
 
(pH 7.0)  
Cellular 
localization 
eZinCh-2
[12]
  Cerulean/Citrine
a
  1.0 nM  cytosol  
ER-eZinCh-2
[12]
  Cerulean/Citrine  1.0 nM  ER
c
  
eCALWY-4
[6]
  Cerulean/Citrine  0.63 nM  cytosol  
ER-eCALWY4
[25]
  Cerulean/Citrine  0.63 nM  ER
c
  
redCALWY-4
[10]
  mOrange2/mCherry
b
 0.24 nM  cyotosol  
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Results 
Determination of cytosolic and ER Zn
2+
 concentrations in MCF-7 
and TamR cells using FRET-based Zn
2+
 sensors  
Previous work on MCF-7 and TamR cells using small-molecule 
fluorescent sensors reported increased levels of intracellular Zn
2+
 in 
TamR cells compared to wild-type MCF-7 cells
[22]
, but the 
concentration of free cytosolic Zn
2+
 could not be determined. We 
therefore expressed the eZinCh-2 sensor in the cytosol of both 
MCF-7 and TamR cells and monitored the in situ response in single 
living cells to the addition of the strong membrane-permeable Zn
2+
 
chelator TPEN and excess Zn
2+
 together with pyrithione as a Zn
2+
-
specific ionophore. In both MCF-7 and TamR cells a robust, 3-fold 
change in emission ratio was observed between the Zn
2+
-depleted 
and Zn
2+
-saturated states of the sensor (Figure 1). The 
determination of the emission ratios under conditions of Zn
2+
 
depletion (R0%) and Zn
2+
 excess (R100%) allowed calculation of the 
sensor occupancy under resting conditions, which could be 
translated into a free Zn
2+
 concentration using the Kd of 1 nM. The 
free cytosolic Zn
2+
 concentrations in wild type MCF-7 cells and 
TamR cells were determined to be 0.44 ± 0.06 nM and 0.65 ± 0.06 
nM, respectively. Although the free Zn
2+
 concentration in TamR 
cells appears to be slightly higher, both numbers  agree well with 
values determined previously in other mammalian cell types, and 
neither of them is particularly high
[6]
.  
 
Figure 1: (A,B) Determination of the free cytosolic Zn2+ concentration in wild-
type MCF-7 (A) and TamR cells (B) using eZinCh-2. Responses to the addition of 
50 µM TPEN, followed by the addition of excess 100 µM Zn2+/ 5 µM pyrithione. 
All traces in A and B represent the average of at least four cells after 
normalization of the emission ratio at t=0 s. Error bars represent the standard 
error of the mean (SEM). (C) False-colored ratiometric images of an MCF-7 cell 
expressing eZinCh-2 in resting state (Resting), after perfusion with 50 µM TPEN 
(+TPEN), and 100 µM ZnCl2/5 µM pyrithione (+Zn
2+/pyr). Scale bar, 10 µM. 
To explore a possible correlation between the increased ZIP7 
expression and free ER Zn
2+
 levels in TamR cells, 
[22]
 the ER-
targeted FRET-based Zn
2+
 sensors ER-eZinCh-2 and ER-
eCALWY-4 were expressed in both wild-type MCF-7 and TamR 
cells
[24]
 (Table 1; Figure 2 and 3). Colocalization studies showed 
exclusive localization of these sensors to the ER lumen. Using 
ER-eZinCh-1, addition of TPEN and excess Zn
2+
 yielded similar 
response curves as were found previously for HeLa and 
HEK293T cells
[11]
, yielding free ER Zn
2+
 concentrations of 0.54 ± 
0.27 nM for MCF-7 (Figure 2C) and 0.75 ± 0.49 nM for TamR 
cells (Figure 2D). Measurements using ER-targeted eCALWY-4 
yielded similar ER Zn
2+
 concentrations of 0.39 ± 0.17 nM and 
0.21 ± 0.05 nM for MCF-7 (Figure 3C) and TamR cells (Figure 
3D), respectively.  
The average free ER Zn
2+
 concentrations that were found are 
similar to those found in the cytosol, although the cell-to-cell 
variation in free Zn
2+
 concentration was found to be larger in 
the ER when compared to the cytosol. The latter may reflect 
less efficient buffering of the free Zn
2+
 concentration due to a 
lack of metallothionein in the ER. 
 
 
 
 
 
 
Figure 2: 
Zn2+ imaging using ER-targeted eZinCh-2 in both MCF-7 and TamR cells. (A) 
Schematic representation of eZinCh-2 containing an N-terminal signal sequence 
(PPI) and a C-terminal retention sequence (KDEL). (B) False-colored image 
showing MCF-7 cells expressing ER-eZinCh-2. (C, D) Responses of MCF-7 (C) and 
TamR (D) cells expressing ER-eZinCh-2 to the addition of 50 µM TPEN, and the 
subsequent addition of excess Zn2+ together with pyrithione (100 µM/5 µM). All 
traces in represent the average of four cells after normalization of the emission 
ratio at t=0 s. Error bars represent SEM. 
 
 
 
 
 
 
 
 
Figure 3: Zn2+ imaging using ER-targeted eCALW-4 in both MCF-7 and TamR cells. 
(A) Schematic representation of eCALWY-4 containing a PPI and a KDEL 
sequence. (B) False-colored image showing a TamR cells expressing ER-eCALWY-
4. (C, D) Responses of MCF-7 (C) and TamR (D) cells expressing ER-eCALWY-4 to 
the addition of 50 µM TPEN, and the subsequent addition of Zn2+/pyrithione. All 
traces in represent the average of four cells after normalization of the emission 
ratio at t=0 s. Error bars represent SEM. 
 
Page 3 of 7 Metallomics
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
M
et
al
lo
m
ic
s
A
cc
ep
te
d
M
an
us
cr
ip
t
O
pe
n 
A
cc
es
s A
rti
cl
e.
 P
ub
lis
he
d 
on
 2
4 
D
ec
em
be
r 2
01
5.
 D
ow
nl
oa
de
d 
on
 0
4/
01
/2
01
6 
12
:4
9:
44
. 
 
Th
is 
ar
tic
le
 is
 li
ce
ns
ed
 u
nd
er
 a
 C
re
at
iv
e 
Co
m
m
on
s A
ttr
ib
ut
io
n 
3.
0 
U
np
or
te
d 
Li
ce
nc
e.
View Article Online
DOI: 10.1039/C5MT00257E
ARTICLE Journal Name 
4 | J. Name., 2012, 00, 1-3 This journal is © The Royal Society of Chemistry 20xx 
Please do not adjust margins 
Please do not adjust margins 
MCF-7 cells
0 200 400 600 800
0
10
20
30
Zn2+/pyr
Time (seconds)
N
o
rm
a
liz
e
d
 f
lu
o
re
s
c
e
n
c
e
in
te
n
s
ity
 (
A
.U
)
MCF-7 cells
0 200 400 600 800
0
5
10
15
20
Zn2+/pyr
Time (seconds)
N
o
rm
a
liz
e
d
 f
lu
o
re
s
c
e
n
c
e
in
te
n
s
ity
 (
A
.U
)
TamR cells
0 200 400 600 800
0
10
20
30
Zn2+/pyr
Time (seconds)
N
o
rm
a
liz
e
d
 f
lu
o
re
s
c
e
n
c
e
in
te
n
s
ity
 (
A
.U
)
TamR cells
0 200 400 600 800
0
5
10
15
20
25
Zn2+/pyr
Time (seconds)
N
o
rm
a
liz
e
d
 f
lu
o
re
s
c
e
n
c
e
in
te
n
s
ity
 (
A
.U
)
A B
C D
ER-eZinCh-2
0 200 400 600 800
0.5
1.0
1.5
2.0
Zn2+/pyr
Time (seconds)
N
o
rm
a
liz
e
d
 f
lu
o
re
sc
e
n
ce
 i
n
te
n
si
ty
ra
ti
o
 (
C
it
ri
n
e
/C
e
ru
le
a
n
)
ER-eCALWY-4
0 200 400 600 800
0.5
0.6
0.7
0.8
0.9
1.0
1.1
Zn2+/pyr
Time (seconds)
N
o
rm
a
liz
e
d
 f
lu
o
re
sc
e
n
ce
 i
n
te
n
si
ty
ra
ti
o
 (
C
it
ri
n
e
/C
e
ru
le
a
n
)
A B
Monitoring changes in intracellular Zn
2+
 levels upon external Zn
2+
 
stimulation 
Previous studies using FluoZin-3 showed a delayed increase in 
intracellular Zn
2+
 upon extracellular addition of 20 µM Zn
2+
 and 
10 µM pyrithione, which was interpreted to result from ZIP7-
dependent Zn
2+
 release from ER stores into the cytosol
[21]
. 
Because pyrithione is normally used to transfer Zn
2+
 ions 
across biological membranes, one would expect to observe a 
large and immediate increase in intracellular Zn
2+
 levels upon 
Zn
2+
/pyrithone treatment but the cells in the previous study 
were fixed prior to imaging. To check whether the same results 
could be obtained in live cells, we repeated these imaging 
experiments on live MCF-7 and TamR cells loaded with 
FluoZin-3 AM. A perfusion setup was used to allow continuous 
flow over the cells during the imaging experiments. In this 
experimental setup, addition of external Zn
2+
 resulted in a 
large increase in emission ratio immediately after addition of 
20 µM Zn
2+
/10 µM pyrithione for both wild-type MCF-7 (Figure 
4A and B) and TamR cells (Figure 4C and D). A large variation in 
absolute fluorescent signal intensity was observed after Zn
2+
 
addition between individual cells, which may reflect the 
difficulty to control the intracellular concentration of FluoZin-3 
Nonetheless, in contrast to previous work using fixed cells, 
these life cell imaging experiments reveal an almost immediate 
increase in fluorescence intensity in all cells with a half-time of 
about 60 seconds after exposure to Zn
2+
/pyrithione. 
 
Figure 4: (A,B) Responses of MCF-7 cells loaded with FluoZin-3 AM to the 
addition of 20 µM Zn
2+
 together with the Zn
2+
-specific ionophore pyrithione, 
monitored in real time. (C, D) Responses of TamR cells loaded with FluoZin-3 AM 
to the addition of 20 µM Zn
2+
 together with the Zn
2+
-specific ionophore 
pyrithione, monitored in real time. Traces in B and D represent the average of 
four and three cells, respectively, after normalization at t=0 s. Error bars 
represent SEM. 
This fast increase in fluorescence is consistent with direct 
pyrithione-mediated transfer of Zn2+ from the cell exterior 
into the cytoplasm, without the need to invoke intracellular 
release of Zn2+ from the ER. To directly assess the effect of 
stimulation with Zn2+/pyrithione on ER Zn2+ levels, we 
repeated these experiments in MCF-7 and TamR cells 
expressing either ER-ZinCh-2 or ER-eCALWY-4. Addition of 20 
µM Zn2+/10 µM pyrithione to MCF-7 cells expressing ER-
eZinCh-2 resulted in an immediate increase in emission ratio 
(Figure 5A), consistent with an increase in the free ER Zn2+ 
concentration. Comparable responses were observed for TamR 
cells expressing ER-eZinCh-2 (Figure S1). The same 
experiments were performed on both MCF-7 (Figure S2) and 
TamR (Figure 5B) cells expressing ER-eCALWY-4, resulting in a 
decrease in emission ratio upon Zn2+ addition, which again 
corresponds to an increase in free ER Zn2+ levels. The increase 
in ER Zn2+ is inconsistent with a specific release of Zn2+ from 
the ER to the cytoplasm, but is not unexpected given the fact 
that pyrithione can also mediate transfer of Zn
2+
 across the 
intracellular ER membrane.   
 
Figure 5: (A) Responses of MCF-7 cells expressing ER-eZinCh-2 to the addition of 
20 µM Zn2+/10 µM pyrithione. (B) Responses of TamR cells expressing ER-
eCALWY-4 to the addition of 20 µM Zn2+/10 µM pyrithione. Traces in A and B 
represent the average of three cells after normalization at t=0 s. Error bars 
represent SEM. 
Monitoring changes in intracellular Zn
2+
 upon stimulaton with EGF 
and ionomycin  
 A combination of epidermal growth factor (EGF) and the 
calcium ionophore ionomycin has been reported previously to 
trigger release of Zn
2+
 from the ER resulting in so-called Zn
2+
 
waves in the cytosol of mast cells.
[3]
 Using the synthetic Zn
2+
 
probe Zinquin (Kd = 7 µM), a comparable increase in cytosolic 
Zn
2+
 concentration has been reported in TamR cells upon 
addition of EGF and ionomycin
[21]
. To obtain independent 
evidence for the putative release of Zn
2+
 from the ER into the 
cytosol upon EGF/ionomycin stimulation, we simultaneously 
used redCALWY-4 to monitor cytosolic Zn
2+
 levels and either 
ER-eZinCh-2 or ER-eCALWY-4 to monitor changes in ER Zn
2+
 
concentrations
[10]
. Both cell lines showed good co-expression 
levels of these proteins. Imaging experiments were again 
performed using a perfusion setup, starting with perfusion of 
imaging buffer followed by addition of buffer supplemented 
with 10 ng/mL EGF and 500 nM ionomycin (Figure 6). When 
Zn
2+
 would be released from the ER to the cytosol upon 
external stimulation, a decrease in the emission ratio of 
redCALWY-4 and ER-eZinCh-2 should be observed, while an 
increase in emission ratio would be expected for ER-eCALWY-
4. However, no changes in emission ratio were observed upon 
perfusion with EGF and ionomycin in either the cytosol or the 
ER (Figure 6). Different combinations of sensors were tested 
for both wild-type MCF-7 and TamR cells, but none of these 
experiments revealed a detectable change in either cytosolic 
or ER Zn
2+
 levels. 
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Figure 6: (A) Responses of MCF-7 cells co-expressing redCALWY-4 and ER-eZinCh-
2 to the addition of 10 ng/mL EGF together with 500 nM ionomycin. (B) 
Responses of TamR cells co-expressing redCALWY-4 and ER-eCALWY-4 to the 
addition of 10 ng/mL EGF together with 500 nM ionomycin. Traces in A and B 
represent the average of three cells after normalization at t=0 s. Error bars 
represent SEM. 
To exclude the possibility that the lack of response to 
EGF/ionomycin was somehow a result of the multicolor 
imaging experiments, we repeated these experiments in single 
sensor experiments. In these experiments the classical 
cerulean/citrine-based probes can be used for cytosolic 
imaging. The higher dynamic range of these sensors compared 
to the redCALWY probes should make it easier to detect small 
changes in cytosolic Zn
2+
 levels. However, no changes in 
emission ratio were observed following addition of EGF and 
ionomycin in MCF-7 cells (Figure 7A) or TamR cells (Figure 7B) 
transfected with either eZinCh-2 or eCALWY-4. Similarly, 
EGF/ionomycin addition did not provoke any sensor response 
in either MCF7 or TamR cells expressing ER-eZinCh-2 or ER-
eCALWY-4 (Figure 7C/D).  
 
 
Figure 7: Responses of MCF-7 cells expressing cytosolic eCALWY-4 (A) and TamR 
cells expressing cytosolic eZinCh-2 (B) to the addition of 10 ng/mL EGF together 
with 500 nM of the calcium ionophore ionomycin. Responses of MCF-7 cells 
expressing ER-eZinCh-2 (C) and TamR cells expressing ER-eCALWY-4 (D) to the 
addition of 10 ng/mL EGF together with 500 nM of the calcium ionophore 
ionomycin. All traces represent the average of three cells after normalization at 
t=0 s. Error bars represent SEM. 
 
Discussion and Conclusion 
The previously developed FRET-based Zn
2+
 sensors eZinCh-2 
and eCALWY-4 were successfully used to test the hypothesis 
that exposure of wild-type MCF-7 and TamR cells to external 
stimuli results in ZIP7-dependent Zn
2+
 release from the ER 
stores into the cytosol
[21]
. Our work provided the first accurate 
determination of the free Zn
2+
 concentrations in these breast 
cancer cell lines and revealed that free Zn
2+
 concentrations are 
similar to those reported previously in other cell lines, both in 
the cytosol and the ER
[6]
. In contrast to previous reports using 
a synthetic fluorescent sensor and fixed cells, the genetically 
encoded sensors showed that addition of external Zn
2+
 and the 
Zn
2+
-specific ionophore pyrithione results in an immediate 
increase in both cytosolic and ER Zn
2+
. This result is important, 
because external Zn
2+
/pyrithione was previously hypothesized 
to induce an intracellular signaling cascade resulting in ZIP7-
mediated release of Zn
2+
 from the ER to the cytosol. Another 
treatment that had been implicated to trigger specific release 
of Zn
2+
 from the ER to the cytosol, EGF and ionomycin, was 
extensively tested in live cell imaging experiments in cells 
expressing a cytosolic sensor, an ER-targeted sensor or a 
combination of both. No changes in emission ratio were 
observed in either the cytosol or the ER in either MCF7 cells or 
TamR cells. These results suggest that EGF/ionomycin 
treatment does not trigger Zn
2+
 release from the ER into the 
cytosol.  
 An important difference between this work and previous 
reports is the use of genetically encoded sensors instead of 
small-molecule dyes. Using the Zn
2+
-specific fluorescent dye 
FluoZin-3, Taylor and coworkers did not observe an immediate 
increase in fluorescence after the addition of Zn
2+
/pyrithione, 
which is surprising because pyrithione is a Zn
2+
-specific 
ionophore that transfers Zn
2+
 across the plasma membrane. 
One possible explanation is that the fixation protocol that was 
used previously interfered with accurate and early detection of 
increases in Zn
2+
 concentration. E.g. fixation does not allow 
continuous monitoring of the free Zn
2+
 concentration in the 
same cell and cells on different coverslips were  required for 
each time point after Zn
2+
 treatment. Finally, unlike genetically 
encoded FRET sensors that can easily be targeted to a specific 
place in the cell, FluoZin-3 has been shown to not be 
exclusively localized in the cytosol, but also present in other 
subcellular compartments
[23]
.   
 In contrast to previous studies using Zinquin, no detectable 
changes in emission ratio were observed using our genetically 
encoded sensors in either MCF-7 or TamR cells following 
addition of EGF/ionomycin, neither in the cytosol nor when 
the sensors were targeted to the ER. Because the affinity of 
Zinquin that was used in previous studies is relatively low (Kd = 
7 µM), increasing levels of cytosolic Zn
2+
 upon EGF/ionomycin 
treatment should have been easily detectable by the sensors 
used in this study, eZinCh-2 (Kd = 1 nM at pH 7.1) and eCALWY-
4 (Kd = 0.63 pM at pH 7.1)(Table 1). We therefore conclude 
that addition of external EGF together with ionomycin does 
not trigger release of Zn
2+
 from the ER stores into the cytosol. 
Previous experiments with EGF/ionomycin were also 
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performed on fixed cells, which holds the same limitations as 
discussed above. It may therefore be worthwhile to apply 
genetically encoded sensors also in other cell systems in which 
treatment with EGF/ionomycin has been reported to result in a 
transient increase in cytosolic Zn
2+
 levels such as the Zn
2+
 
waves reported by Yamasaki and coworkers in mast cells.
[3]
. 
 Having shown that addition of Zn
2+
 together with 
pyrithione results in an immediate increase in cytosolic and ER 
free Zn
2+
 concentrations, our results do not support the 
suggested Zn
2+
 release from the ER several minutes after this 
treatment. In addition, no changes in overall cytosolic or ER 
free Zn
2+
 levels were observed upon addition of 
EGF/ionomycin using our genetically encoded sensors. Other 
observations that were originally linked to the release of Zn
2+
 
from the ER may therefore also need to be reconsidered. For 
example, the association of protein kinase CK2 with ZIP7, and 
the subsequent phosphorylation of ZIP7, could be a 
downstream consequence of the pyrithione-mediated increase 
in cytosolic Zn
2+
. Similarly,  the reported activation of 
downstream signaling pathways may occur through 
phosphatase inhibition
[20]
. Addition of 20 µM Zn
2+
 together 
with 10 µM pyrithione will increase the level of cytosolic free 
Zn
2+
 level to at least several nanomolar, which is sufficient to 
directly inhibit phosphatases
[25]
. Since no changes in overall 
intracellular Zn
2+
 levels were observed upon treatment with 
EGF/ionomycin, another mechanism may need to be invoked 
to explain the increased levels of tyrosine phosphorylation 
observed after treatment with this trigger. Alternatively, 
phosphatase inhibition may result from transient increases in 
local Zn
2+
 concentrations that cannot be detected using the 
current sensor technology.  
 
In conclusion, the present study using genetically encoded 
FRET sensors  does not provide supportive evidence for ZIP7-
mediated release of Zn
2+
 from ER stores into the cytosol in 
TamR cells.  These unexpected results suggest that it may be 
worthwhile to apply the specific properties of genetically 
encoded FRET sensors to carefully reassess other examples of 
triggered Zn
2+
 release from intracellular stores. 
Experimental Section 
Mammalian cell culture and transfection 
MCF-7 and TamR cells were cultured in Roswell Park Memorial 
Institute media (RPMI), supplemented with 5% (v/v) fetal calf 
serum (FCS), 2 mM glutamine, 1 mM fungizone, 100 U/mL 
penicillin, and 100 µg/mL streptomycin (all from Life 
Technologies) at 37 °C in a humidified atmosphere containing 
5% CO2. For TamR cells stripped fetal calf serum (SFCS) was 
used instead of FBS and 0.1 µM 4-hydroxytamoxifen (4-OH 
tamoxifen) was added to the media. Cells were seeded on 
glass coverslips (ᴓ 30 mm, VWR) one day before transfection. 
About 200 000 cells were seeded to reach a confluency of ~ 
80% on the day of transfection. Lipofectamine 2000 (Life 
Technologies) was used to carry out transfections, following 
the manufacturer’s instructions. Cells were imaged either one 
day (single sensor experiments) or two days (two sensor 
experiments) after transfection in a HEPES buffer (Live Cell 
Imaging Buffer, Life Technologies) at 37 °C. 
 
Intracellular FRET imaging 
Imaging on MCF-7 and TamR cells was performed with a 
confocal microscope (Leica, TCS SP5X) equipped with a 63x 
water immersion objective, acousto-optical beamsplitters 
(AOBS), a white light laser, and a 405 nM laser. Fluozin-3 AM 
was excited at 494 nm, followed by monitoring its emission 
between 505–530 nm. For all eCALWY-4 and eZinCh-2 
constructs, cerulean was excited using the 405 nm laser. For 
the redCALWY-4 the emission of a white light laser was set to 
550 nm (5% of full power) to excite mOrange2. Emission was 
monitored using the AOBS and avalanche photo 
diode/photomultiplier tubes hybrid detectors (HyD, Leica): 
cerulean (450–500), citrine (515–595 nm), mOrange2 (565–
600), and mCherry (600–630). Images were recorded at either 
7.5 s intervals (two sensor experiments) or at 5 s intervals 
(single sensor experiments). For the in situ calibration 
experiments, cells were imaged for a few minutes with HEPES 
buffer without additives. Next HEPES buffer containing 50 µM 
N,N,N’,N’-tetrakis(2-pyridylmethyl)ethylenediamine (TPEN, 
Sigma) was added, followed by addition of HEPES buffer 
containing 100 µM ZnCl2 and 5 µM of the Zn
2+
-specific 
ionophore 2-mercaptopyridine N-oxide (pyrithione, Sigma), 
with a final concentration of 36 µM TPEN, 100 µM ZnCl2 and 5 
µM pyritione. Zn
2+
 stimulation was performed by perfusion 
with plain HEPES buffer for a few minutes, followed by 
perfusion with HEPES buffer supplemented with 20 µM ZnCl2 
and 10 µM pyrithione (Sigma). For EGF/ionomycin stimulation, 
cells were perfused with HEPES buffer without additives for a 
few minutes, followed by perfusion with HEPES buffer 
containing 10 ng/mL EGF (Sigma, E9644) and 500 nM 
ionomycin (Sigma, 56092-82-1). Image analysis was performed 
using ImageJ software as described before
[24, 26]
. Steady-state 
fluorescence intensity ratio of acceptor over donor was 
measured, followed by the determination of the minimum and 
maximum ratios to calculate the free Zn
2+
 concentration using 
equation 1: 
         (1) 
In which R0% is the ratio in the Zn
2+
 depleted state, after 
addition of 50 µM TPEN, and R100% was obtained upon Zn
2+
 
saturation with 100 µM ZnCl2 in the presence of 5 µM 
pyrithione
[6, 24]
.  
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